Accumulating studies indicated high expression level of CENPF is associated with progress and prognosis in prostate cancer 20,21, breast cancer 22, hepatocellular carcinoma 23,24, esophageal squamous cell carcinoma 25 and nasopharyngeal carcinoma 26. This evidence concerns the gene CENPF and nasopharyngeal carcinoma.